AIM WINNERS & LOSERS: Open Orphan rises on asthma study contract win Read More
Open Orphan shares lift on GBP8.1 million asthma study contract win Read More
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million Read More
AIM WINNERS & LOSERS: Restore rises as it rebuffs Marlowe approach Read More
UK shareholder meetings calendar - next 7 days Read More
IN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPO Read More
IN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debut Read More
Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug Read More
AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle Read More
Open Orphan reports widened 2020 loss; Poolbeg mulls London float Read More
AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough Read More
UK earnings, trading statements calendar - next 7 days Read More
TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment Read More
TRADING UPDATES: Begbies buys finance broker; Amino Tech makes US bid Read More
EXECUTIVE CHANGES: New Cenkos CEO gets FCA nod; Feedback hires CFO Read More
Open Orphan launches new data platform to combat infectious diseases Read More
TRADING UPDATES: Renew to buy J Browne; Idox in good start to year Read More
TRADING UPDATES: SpaceandPeople swings to loss in 2020 amid virus Read More
IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics Read More
IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval Read More
